Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study

PaperCitations, authors & open-access status

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 128 citations, 2021 year and closed oa status.

128
Citations
2021
Year
closed
OA Status

Related on ScholarIQ

Sareh Keshavarzi
Author
European Urology
Journal
Renal cell carcinoma treatment
Topic
Renal cell carcinoma treatment
Topic
Brain Metastases and Treatment
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
470M+ articles · free account